Search for: "PREFERRED PHARMACEUTICALS, INC" Results 1 - 20 of 331
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Mar 2014, 7:55 pm by FDABlog HPM
  The defendants are Endo Health Solutions, and its subsidiary, Endo Pharmaceuticals Inc., based in Malvern, Pennsylvania. [read post]
31 Oct 2011, 12:21 pm by fraudfighters
DFine was accused of using User Preference Evaluations (UPE) to induce physicians into using their products.  [read post]
15 Dec 2011, 6:00 am by SECLaw Staff
Stiefel Laboratories Inc is a subsidiary of pharmaceutical company GlaxoaSmithKline and was the world's largest private manufacturer of dermatology products. [read post]
17 Oct 2014, 7:23 am by Amy Howe
Sandoz, Inc., emphasizing that “[l]ast year’s patent decisions revealed a strong preference by the Supreme Court to tell the Federal Circuit that it should stop thinking of itself as Lord of the Patents, and that ‘supreme’ means just what it sounds like. [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
17 Jun 2013, 9:01 pm by Howard Ullman
Actavis, Inc. and held, in a 5-3 decision authored by Justice Breyer, that so-called reverse-payment patent settlements are subject to full antitrust Rule of Reason analysis. [read post]
31 Aug 2017, 5:34 pm by FDABlog HPM
Court of Appeals for the District of Columbia Circuit isued a 31-page Opinion handing FDA a victory in a dispute kicked off by Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceuticals Co., Ltd. [read post]